A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder	Active, not recruiting	Phase 1 / Phase 2	2026-04-14		NCT06405633

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Wave Life Sciences USA, Inc.	4

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cambridge University - Addenbrooke's Hospital	Cambridge	United Kingdom	3
Dalhousie University - Queen Elizabeth II Health Sciences Centre	Halifax	Canada	1
Inspiration Research Limited	Toronto	Canada	5
Queen Elizabeth Hospital, University Hospital Birmingham	Birmingham	United Kingdom	2
Royal Free London NHS Foundation Trust	London	United Kingdom	1
St. Vincent's Hospital, Melbourne	Fitzroy	Australia	1
Turku University Hospital	Turku	Finland	27
Universitaetsklinikum Aachen, AoeR	Aachen	Germany	2
Waikato Hospital	Hamilton	New Zealand	21